AKT1 and cancer: The possible molecular mechanism involves inhibiting cleaved CASP3, MMP3, SRC, MAPK10 and CDK6, and activating PPARα and JAK, which are typically involved in cancer pathways, the PI3K-Akt signaling pathway and viral carcinogenesis pathways.